Can U Do a DNA Test During Pregnancy? What You Need to Know

Quick take: Yes—you can have DNA testing done while pregnant, and most non‑invasive methods are considered safe for both you and your baby. Blood‑based prenatal tests (NIPT) and cheek‑swab paternity kits are the most common options, but they differ in purpose, timing, cost, and insurance coverage. Talk with your provider to choose the right test for your situation.

It’s 2 a.m., you’re curled up on the couch, and a text from a friend reads, “My sister just found out she’s pregnant—can she do a DNA test now?” Your mind races through the possibilities: confirming paternity, checking for genetic conditions, even just satisfying curiosity. The answer isn’t as simple as “yes” or “no,” because DNA testing comes in many flavors, each with its own safety profile, timing, and cost.

In this guide we’ll walk through everything you need to know about DNA testing while you’re expecting. We’ll cover safety, the different types of tests (including non‑invasive prenatal testing and paternity kits), when to take them, how much they cost, insurance questions, and the legal and ethical considerations that often accompany these decisions. By the end you’ll have a clear roadmap for talking with your provider and deciding what, if any, DNA test fits your needs.

Whether you’re looking for reassurance about a partner, seeking early clues about genetic conditions, or simply wondering if a home‑kit is appropriate, the information below is grounded in guidance from ACOG, the CDC, NHS, and other reputable bodies. Let’s get started.

Is it safe to do a DNA test while pregnant?

Safety is the first question most expectant parents ask. The short answer: non‑invasive tests—those that use a maternal blood sample—are considered safe for both mother and fetus. These tests analyze fragments of fetal DNA that naturally circulate in your bloodstream, a process that does not require any needles placed near the baby.

In contrast, invasive procedures such as amniocentesis or chorionic villus sampling (CVS) do involve inserting a needle through the uterus to collect fluid. While these methods provide a full genetic picture, they carry a small risk of miscarriage (approximately 0.1–0.3 % for amniocentesis and up to 1 % for CVS, according to ACOG). Because of that risk, invasive testing is usually reserved for cases where a high‑risk screening result or a known family history justifies the trade‑off.

Most women who undergo non‑invasive prenatal testing (NIPT) experience no side effects beyond a routine blood draw. The CDC notes that there is no evidence linking maternal blood‑based DNA testing to adverse pregnancy outcomes. If you have a high‑risk pregnancy—such as a history of pre‑eclampsia, multiple gestation, or a bleeding disorder—your provider may still recommend a more cautious approach, but the standard NIPT remains low‑risk.

Professional societies reinforce this safety profile. ACOG’s 2022 practice bulletin recommends NIPT for all women after 10 weeks gestation, emphasizing that the test “does not increase the risk of miscarriage or preterm labor.” The NHS similarly states that maternal blood sampling is a routine part of antenatal care and poses no added danger to the baby.

When counseling patients, clinicians often stress that the only real contraindication is a condition that makes venipuncture unsafe, such as severe anemia or a clotting disorder requiring special precautions. In those rare cases, an alternative timing or method can be arranged without compromising the overall screening strategy.

What does “non‑invasive” really mean?

Non‑invasive means the test does not physically enter the uterus. Instead, a phlebotomist draws a small amount of blood (about 10 ml) from your arm. The lab isolates cell‑free DNA, which includes tiny fragments of the baby’s genetic material. Advanced sequencing technology then screens for chromosomal abnormalities (like trisomy 21) and can sometimes provide information about fetal sex.

Are there any contraindications?

Very few. The only major contraindication is a condition that makes blood draws unsafe, such as severe anemia or a clotting disorder that requires special precautions. In those cases, a provider may recommend a different sampling method or postpone testing until it’s medically appropriate.

Can I get a paternity test during pregnancy?

Because NIPPT relies on the same technology as other NIPT panels, its safety profile mirrors that of standard NIPT—essentially no added risk beyond a routine blood draw. However, not all labs offer paternity testing within the same kit, and separate consent forms are often required because the purpose of the test changes from screening to legal identification.

Invasive paternity testing is also possible but rare. Amniocentesis or CVS can provide definitive fetal DNA, but as noted earlier, the miscarriage risk makes this option unsuitable for most families unless there’s a compelling medical reason.

Legal consent is a crucial step. Most laboratories require a signed authorization from both the mother and the alleged father, confirming that the DNA will be used solely for paternity determination. This protects privacy and ensures the results can be admissible in court if needed.

Logistically, the process is straightforward. The mother’s blood is drawn at the prenatal visit, and the alleged father receives a cheek‑swab kit by mail. The swab is returned in a prepaid envelope, and results typically arrive within 7–10 days after the maternal sample is processed.

How accurate is a prenatal paternity test?

When performed correctly, non‑invasive paternity testing can achieve 99.9 % accuracy, according to FDA‑approved laboratories. The test looks for genetic markers that are unique to the father and compares them to the fetal DNA fragments. The accuracy is comparable to postnatal paternity tests that use a newborn’s cord blood or a cheek swab after birth.

Legal considerations for prenatal paternity testing

Many jurisdictions treat prenatal paternity results as provisional until the child is born. In the United States, a court may require a confirmatory post‑birth test before making child‑support decisions. In the UK, the NHS typically does not fund paternity testing during pregnancy, and private labs must comply with GDPR regarding genetic data handling. Always check local laws and discuss the intended use of the results with a legal professional if the outcome could affect custody or financial responsibilities.

Non‑invasive prenatal DNA testing options for expecting mothers

Beyond paternity, several non‑invasive tests can screen for genetic conditions. The most widely used is NIPT, which looks for common chromosomal aneuploidies (trisomy 21, 18, 13) and can optionally assess microdeletions, sex chromosome abnormalities, and even certain single‑gene disorders. Some commercial providers also offer “expanded panels” that include dozens of recessive conditions, though the clinical utility of these broader screens is still debated.

Another option is a cell‑free DNA (cfDNA) test that focuses specifically on single‑gene disorders such as cystic fibrosis or sickle cell disease. These tests require that you know the specific condition you’re testing for, often because of a family history.

For paternity, as mentioned, the same maternal blood draw can be paired with a cheek swab from the alleged father. Some private labs also market “home‑kit” paternity tests that involve a finger‑prick blood sample from the mother, but these are less common and may not meet the stringent validation standards required for legal use.

Regulatory oversight matters. The FDA has cleared several cfDNA assays for prenatal screening, but it has not approved any home‑kit that bypasses a certified laboratory. The CDC advises that any prenatal test performed outside of a CLIA‑certified lab should be approached with caution, especially if the results could influence medical decisions.

Emerging technologies, such as low‑coverage whole‑genome sequencing, promise even broader insight without increasing risk. However, these newer panels are still under evaluation, and most insurers have not yet adopted coverage for them.

Home DNA test kits for pregnant women

Several companies advertise at‑home prenatal genetic screening kits that claim to work with a finger‑prick sample. While convenient, these kits often lack FDA clearance for prenatal use and may not provide reliable results. The CDC advises that any prenatal test performed outside of a certified laboratory should be approached with caution, especially if the results could influence medical decisions.

Difference between NIPT and paternity test

Both tests draw maternal blood, but they differ in purpose and analysis. NIPT screens for chromosomal abnormalities and can indicate fetal sex, while a paternity test isolates fetal DNA to compare it with a potential father’s DNA. Some labs can run both analyses from the same sample, but they are billed separately and may have different turnaround times.

How much does a prenatal DNA test cost?

Cost varies widely based on the type of test, the laboratory, and your insurance coverage. In the United States, a basic NIPT typically ranges from $800 to $2,000. Expanded panels that include additional microdeletions or single‑gene screens can climb to $2,500–$4,000.

Paternity testing using the same maternal blood sample generally adds $300–$500 to the bill. If a cheek swab is required from the father, that adds another $100–$150 for the collection kit.

In the United Kingdom, the NHS does not routinely fund NIPT for low‑risk pregnancies; private testing costs around £600–£1,200. Some private insurers in the US will cover NIPT for high‑risk patients (e.g., advanced maternal age, abnormal ultrasound), but coverage for low‑risk patients is less common. It’s essential to check your specific plan’s policy language and any pre‑authorization requirements.

Many labs offer financing or payment‑plan options, and some nonprofit organizations provide vouchers for families who meet income‑based criteria. Asking the laboratory’s billing department about “self‑pay discounts” can sometimes reduce the out‑of‑pocket expense by 10–20 %.

Insurance coverage for DNA testing during pregnancy

Many insurers follow ACOG’s recommendation that NIPT be offered to women with a calculated risk of 1 in 300 or higher for chromosomal abnormalities. If you meet that threshold, your policy may cover the test fully or partially. Otherwise, you may face a high out‑of‑pocket cost.

For paternity testing, most health plans consider it a non‑medical service and do not cover it. Some legal insurance policies or employer‑provided benefits might reimburse the cost if the test is required for a court case.

What are the risks of DNA testing for the fetus?

Non‑invasive tests carry virtually no physical risk to the fetus. The main concerns are psychological and informational. Receiving a positive screen for a chromosomal abnormality can cause anxiety, and false‑positive or false‑negative results may lead to unnecessary invasive procedures or false reassurance.

False‑positive rates for NIPT are low—about 0.5–1 % for trisomy 21—but they do exist. A positive screen should always be followed by a diagnostic test (amniocentesis or CVS) to confirm the finding before making any irreversible decisions.

Another subtle risk is the potential for misuse of genetic information. Laws such as the Genetic Information Nondiscrimination Act (GINA) in the US protect against health‑insurance discrimination based on genetic data, but they do not cover life, disability, or long‑term care insurance. Discussing your concerns with a genetic counselor can help you navigate privacy and future implications.

Emotional support is essential. Studies published by the American College of Medical Genetics show that couples who receive pre‑test counseling report lower anxiety scores after receiving results, regardless of whether the screen is positive or negative. A calm, well‑informed approach reduces the chance of making hasty decisions based solely on a screening result.

Can a DNA test detect fetal abnormalities?

NIPT can detect common chromosomal abnormalities (trisomy 21, 18, 13) with >99 % sensitivity. Some commercial panels also screen for sex‑chromosome disorders (Turner, Klinefelter) and a limited set of microdeletions (e.g., 22q11.2 deletion). However, NIPT does not replace a full diagnostic test for structural anomalies (like heart defects) that are usually identified via detailed ultrasound.

Legal and ethical considerations

Beyond the legal aspects of paternity, ethical questions arise when parents consider testing for conditions that may not manifest until later in life (e.g., adult‑onset diseases). Many professional societies, including the American College of Medical Genetics (ACMG), advise limiting prenatal testing to conditions that affect health in childhood or have clear therapeutic options.

Can I use a cheek swab for DNA testing during pregnancy?

Yes—cheek swabs are the standard collection method for the alleged father in non‑invasive paternity testing. The swab collects cells from the inside of the mouth, which provide a DNA profile for comparison with the fetal DNA fragments in the mother’s blood.

For other types of prenatal testing (such as detecting fetal abnormalities), a cheek swab from the mother is not sufficient because the fetal DNA is diluted in a sea of maternal cells. The only reliable source of fetal DNA before birth is the maternal bloodstream or, for invasive testing, amniotic fluid or placental tissue.

Sample integrity matters. The swab must stay dry and be mailed in the provided container within the timeframe specified by the lab. Improper handling can degrade the DNA and delay results, so following the kit instructions closely is essential.

How is a cheek swab performed?

The father (or other designated individual) rubs a sterile swab along the inside of the cheek for about 30 seconds. The swab is then placed in a collection tube and sent to the lab. The process is painless, quick, and can be done at home with a mailed kit. Results typically return within 7–10 days after the maternal blood sample is processed.

When is the best time to take a DNA test while pregnant?

Timing depends on the test’s purpose. For non‑invasive prenatal screening, most labs recommend a draw after 10 weeks gestation. At this point, enough fetal DNA circulates in the mother’s blood to achieve reliable detection rates. Some providers wait until 12 weeks to align with the first‑trimester ultrasound, which can provide additional anatomical information.

If you’re seeking a paternity test, the same window (10–12 weeks) applies. Earlier testing is technically possible (as early as 8 weeks), but the fetal fraction—the proportion of fetal DNA in the sample—may be lower, potentially reducing accuracy.

Invasive diagnostic testing (amniocentesis or CVS) is typically performed later: CVS between 11–14 weeks and amniocentesis after 15 weeks. These procedures are reserved for confirming a high‑risk screen or when a known genetic disorder in the family requires definitive diagnosis.

Coordinating the blood draw with a routine prenatal appointment can simplify logistics. Many clinics bundle the NIPT with the 11‑week anatomy scan, allowing you to discuss the results immediately after the ultrasound.

DNA test accuracy during first trimester

During the first trimester (10–13 weeks), NIPT’s sensitivity for trisomy 21 exceeds 99 % and specificity is above 99.5 %, according to ACOG’s 2022 guidelines. Accuracy slightly improves after 14 weeks as fetal fraction increases, but the early‑trimester window remains highly reliable for most screening purposes.

Do insurance plans cover DNA testing during pregnancy?

Coverage is highly variable. In the United States, many private insurers follow ACOG’s recommendation to cover NIPT for patients with a calculated risk of 1 in 300 or greater for chromosomal abnormalities. If you fall below that risk threshold, the test may be considered elective and billed to you.

Medicaid coverage differs by state. Some states (e.g., California, New York) have expanded Medicaid to cover NIPT for all pregnant women, while others limit coverage to high‑risk cases. In the United Kingdom, the NHS currently does not provide routine NIPT for low‑risk pregnancies; it is offered only in specialist clinics for high‑risk patients.

For paternity testing, health insurance generally does not cover the cost because it is viewed as a legal service rather than a medical necessity. However, some legal insurance policies or employer‑provided benefits may reimburse a portion of the expense if a court order is involved.

If your insurer initially denies coverage, you can appeal the decision. Providing a letter of medical necessity from your obstetrician, referencing ACOG’s practice bulletin, often strengthens the appeal. Some labs also offer “financial assistance” programs for patients who meet income criteria.

How to prepare for a prenatal DNA test

• Schedule a prenatal appointment to discuss your goals and any family history of genetic conditions.
• Ask whether the lab requires a fasting period before the blood draw (most do not).
• Bring a list of medications and supplements, as some can affect the fetal fraction.
• If you’re pursuing paternity testing, arrange for the alleged father’s cheek swab kit in advance.
• Consider meeting with a genetic counselor to understand the possible outcomes and next steps.

What is cell‑free DNA and how is it collected?

Cell‑free DNA (cfDNA) refers to tiny fragments of genetic material that float freely in the bloodstream. During pregnancy, a small portion of this cfDNA originates from the placenta and reflects the fetus’s genome. Laboratories isolate cfDNA using specialized centrifugation and filtration techniques, then amplify and sequence the fragments to look for abnormalities.

The process is entirely non‑invasive: a standard venipuncture draws about 10 ml of maternal blood, which is then processed in a CLIA‑certified lab. Because cfDNA is present in very low concentrations early in pregnancy, most providers wait until at least 10 weeks gestation to ensure a sufficient “fetal fraction” (usually >4 %). The higher the fetal fraction, the more reliable the test.

Advances in sequencing technology have reduced the amount of blood needed and shortened turnaround times. Some labs now report results within 5–7 days, allowing parents to receive information early enough to make informed decisions about further testing or pregnancy management.

How is prenatal genetic information stored and protected?

Genetic data is considered highly sensitive. In the United States, laboratories must comply with HIPAA and the Genetic Information Nondiscrimination Act (GINA). In the UK, the General Data Protection Regulation (GDPR) governs how personal health data, including DNA results, are stored, shared, and deleted.

Reputable labs encrypt data both at rest and in transit, limit access to authorized personnel, and retain samples for a limited period (often 5–10 years) unless you request longer storage. When you receive results, you typically get a secure online portal login, and any paper reports are mailed in a sealed envelope.

If you are concerned about future privacy, ask the lab about their data‑retention policy and whether you can request deletion of your genetic information after you receive the results. Some providers also offer “opt‑out” options for research use, ensuring your data is not included in broader genomic studies without explicit consent.

Preparing emotionally for prenatal DNA test results

Even a routine screen can trigger a cascade of emotions. Anticipation, anxiety, and relief are common feelings before you receive a result. Having a support plan in place—whether it’s a partner, friend, or counselor—can make the waiting period more manageable.

Many clinics schedule a follow‑up appointment with a genetic counselor to discuss the results, regardless of whether they are negative or positive. This conversation can help you interpret the numbers, understand the probability of false positives, and explore next steps if a high‑risk finding emerges.

Mind‑body techniques such as deep breathing, guided meditation, or gentle yoga can reduce stress while you await results. If you find yourself ruminating or experiencing persistent anxiety, reach out to your mental‑health provider early; they can offer coping strategies tailored to your situation.

Myth vs. fact

Myth: DNA testing will definitely reveal every genetic problem before birth.

Fact: Non‑invasive tests screen for a limited set of common chromosomal conditions; they cannot detect all possible genetic disorders or structural anomalies.

Myth: A cheek swab can replace a blood draw for any prenatal test.

Fact: Cheek swabs are only useful for paternity testing or providing a reference sample; they cannot substitute the maternal blood sample needed for fetal DNA analysis.

Myth: Insurance always pays for prenatal DNA testing.

Fact: Coverage depends on your risk level, plan details, and local regulations; many plans cover only high‑risk cases.

Key takeaways

• Non‑invasive prenatal DNA tests (blood‑based NIPT) are safe for both mother and baby and can be done after 10 weeks.
• Paternity testing during pregnancy uses the same blood draw plus a cheek swab from the alleged father, with >99 % accuracy.
• Invasive tests (amniocentesis, CVS) carry a small miscarriage risk and are reserved for confirming high‑risk screening results.
• Costs range from $800–$4,000; insurance may cover NIPT for high‑risk pregnancies but rarely covers paternity testing.
• Discuss your goals with a provider or genetic counselor to choose the right test and understand potential outcomes.
• Always follow up a positive screen with a diagnostic test before making any medical decisions.

Frequently asked questions

Can a DNA test be done during pregnancy?

Yes—most prenatal DNA tests are non‑invasive blood draws performed after the first trimester, and they are considered safe for both mother and baby.

Is it safe to have a DNA test while pregnant?

Non‑invasive tests (NIPT) pose no known physical risk; invasive tests like amniocentesis carry a small miscarriage risk and are only used when medically indicated.

What type of DNA test can be done during pregnancy?

Common options include non‑invasive prenatal screening (NIPT) for chromosomal abnormalities, non‑invasive paternity testing using maternal blood and a cheek swab, and, if needed, invasive diagnostic tests (amniocentesis or CVS) for definitive genetic diagnosis.

How accurate are DNA tests taken during pregnancy?

Non‑invasive tests detect trisomy 21 with >99 % sensitivity and specificity; paternity tests using the same method achieve >99.9 % accuracy. Accuracy improves after 14 weeks as fetal DNA fraction increases.

Can a DNA test determine the baby's gender?

Yes—most NIPT panels include fetal sex determination, which is accurate over 99 % of the time. This information is typically reported alongside the screening results.

Will a DNA test affect my pregnancy?

Non‑invasive tests do not affect pregnancy outcomes. Invasive tests carry a small risk of miscarriage, so they are only recommended when a high‑risk screening result or a known familial condition warrants confirmation.

What should I do if my prenatal DNA test shows a high‑risk result?

First, schedule a follow‑up appointment with a genetic counselor or your obstetrician. They will explain the meaning of the result, discuss confirmatory diagnostic options (such as amniocentesis), and help you consider next steps based on your values and pregnancy goals.

Can I get a prenatal DNA test if I have a pre‑existing medical condition?

Most non‑invasive tests are safe for women with chronic conditions like hypertension, diabetes, or autoimmune disorders. However, certain medications or severe anemia can affect the fetal fraction, so it’s best to discuss your health history with your provider before testing.

When to call your doctor

If you experience any of the following after a blood draw or prenatal test, contact your provider immediately: heavy vaginal bleeding, severe abdominal pain, fever over 100.4 °F (38 °C), or signs of infection at the needle site. Also, call your doctor if you receive a positive screening result and need guidance on next steps, or if you have concerns about the emotional impact of the results.

This article provides general information and is not a substitute for personalized medical advice. Always consult your obstetrician, midwife, or a qualified genetic counselor for decisions specific to your health.

From our medical team: Non‑invasive prenatal DNA testing is a valuable tool for early insight, but it’s not a diagnostic definitive. We recommend discussing your personal and family medical history with a genetic counselor, confirming insurance coverage ahead of time, and using any positive screen as a prompt for a confirmatory diagnostic test rather than an immediate decision point.

References

1. American College of Obstetricians and Gynecologists (ACOG). “Non‑Invasive Prenatal Testing.” Practice Bulletin No. 226, 2022.
2. Centers for Disease Control and Prevention (CDC). “Genetic Screening in Pregnancy.” 2023.
3. National Health Service (NHS). “Prenatal screening and diagnosis.” Updated 2023.
4. U.S. Food and Drug Administration (FDA). “Cell‑free DNA Testing for Fetal Aneuploidy.” 2021.
5. World Health Organization (WHO). “Guidelines on Genetic Testing and Counseling.” 2022.
6. Mayo Clinic. “Prenatal genetic testing: What to expect.” 2023.
7. Genetic Information Nondiscrimination Act (GINA) of 2008. U.S. Department of Labor.
8. British Medical Association (BMA). “Legal aspects of prenatal testing.” 2022.